Literature DB >> 16417841

Role of glutamate receptors in periventricular leukomalacia.

Frances E Jensen1.   

Abstract

Periventricular leukomalacia is a form of white-matter injury that occurs in the setting of either primary or secondary hypoxia-ischemia in the premature infant. Hypoxia-ischemia induces increases in cerebral extracellular glutamate levels, thereby activating glutamate receptors on a variety of cell types within the white matter. This review examines the evidence of a role for glutamate receptors in white-matter injury and periventricular leukomalacia. Multiple glutamate receptor subtypes exist, and these appear to play differential roles depending on cell type and time after injury. Glutamate receptors are developmentally regulated on neurons and glia, and certain subtypes are transiently overexpressed in developing rodent brain and are expressed on immature oligodendrocytes in human white matter in the premature period. Pharmacologic agents acting on glutamate receptors might represent age-specific therapeutic strategies for the treatment of periventricular leukomalacia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16417841     DOI: 10.1177/08830738050200120401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  19 in total

1.  Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.

Authors:  Lauren L Jantzie; Delia M Talos; Michele C Jackson; Hyun-Kyung Park; Dionne A Graham; Mirna Lechpammer; Rebecca D Folkerth; Joseph J Volpe; Frances E Jensen
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

Review 2.  Epileptogenesis in the immature brain: emerging mechanisms.

Authors:  Sanjay N Rakhade; Frances E Jensen
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

3.  The expression profile of microRNAs in wistar rats with lipopolysaccharide-induced periventricular leukomalacia.

Authors:  Kai Guo; Yang Yang; Jie Qiu; Qing Kan; Xiao-Guang Zhou; Xiao-Yu Zhou
Journal:  J Mol Neurosci       Date:  2013-01-25       Impact factor: 3.444

4.  Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human.

Authors:  Justin M Dean; Matthew D Moravec; Marjorie Grafe; Nicholas Abend; Jennifer Ren; Xi Gong; Joseph J Volpe; Frances E Jensen; A Roger Hohimer; Stephen A Back
Journal:  Dev Neurosci       Date:  2011-08-25       Impact factor: 2.984

Review 5.  Mechanisms of injury to white matter adjacent to a large intraventricular hemorrhage in the preterm brain.

Authors:  Ira Adler; Dan Batton; Bradford Betz; Steven Bezinque; Kirsten Ecklund; Joseph Junewick; Roy McCauley; Cindy Miller; Joanna Seibert; Barbara Specter; Sjirk Westra; Alan Leviton
Journal:  J Clin Ultrasound       Date:  2010-06       Impact factor: 0.910

Review 6.  Cerebral palsy.

Authors:  Michael V Johnston; Alexander H Hoon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 7.  Pathogenesis of cerebral white matter injury of prematurity.

Authors:  O Khwaja; J J Volpe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-03       Impact factor: 5.747

8.  17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain.

Authors:  Bettina Gerstner; Joan Lee; Tara M DeSilva; Frances E Jensen; Joseph J Volpe; Paul A Rosenberg
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

Review 9.  Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.

Authors:  Agustín Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2009-06       Impact factor: 8.661

10.  Dysregulation of FMRP/mTOR Signaling Cascade in Hypoxic-Ischemic Injury of Premature Human Brain.

Authors:  Mirna Lechpammer; Pia Wintermark; Katherine M Merry; Michele C Jackson; Lauren L Jantzie; Frances E Jensen
Journal:  J Child Neurol       Date:  2015-08-03       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.